Health ❯ Healthcare ❯ Cardiology
Risk Factors HFpEF Risks Artificial Intelligence Innovative Treatments Treatment Options Preventive Measures Arrhythmias Cardiovascular Events Fluid Retention Indicators Immune-Fibroblast Interaction Artificial Heart Mortality Rates Patient Outcomes Clinical Trials GLP-1 Medications Warning Signs Symptoms Quality of Life Heart Transplantation Obesity Metrics Monitoring Devices Vericiguat Risk Assessment Patient Education Social Determinants of Health Hospitalization Risk Reduction Medication Adherence Dapagliflozin Inflammation Carotid Ultrasound Drug Treatments Treatment Guidelines Chronic Insomnia AI in Cardiology Patient Management Biventricular Heart Failure Finerenone Management Strategies Cardiac Regeneration Ejection Fraction Atrial Fibrillation Remote Monitoring Heart Failure Treatment Reduced Ejection Fraction HfpEF Symptoms and Treatment Transplant Surgery Wearable Technology Melatonin Use Patient Stories
Findings point to a strong signal in HFpEF, a hard-to-treat subtype, spurring calls for confirmatory trials.
